Xoma Royalty Corporation is a biopharmaceutical company that specializes in the development and commercialization of innovative treatments for various diseases

The company focuses on acquiring and managing a portfolio of royalty interests in therapeutic assets, partnering with biotechnology and pharmaceutical firms to maximize the potential of its investment in cutting-edge therapies. Xoma's strategy often includes collaborating on late-stage clinical developments, allowing it to benefit from future sales and royalties generated by successful product launches, thus driving its mission to enhance patient outcomes while pursuing financial growth through its diverse royalty-based business model.